1 Apr 2011 13:53

Â
Â
For immediate release
1 April 2011
Â
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Â
Total voting rights
Â
Â
In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 31 March 2011 was 190,313,101Â with each share holding one voting right. No shares are held in treasury.
Â
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.
Â
End
Â
For further information please contact:
Â
MedicX Group: +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Â
Collins Stewart Europe Limited: +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Â
Buchanan Communications: +44 (0) 20 7466 5000
Charles Ryland/Suzanne Brocks
Â
MedicX Fund Limited: +44 (0) 1481 723 450
David Staples, Chairman
Â
Â
Information on MedicX Fund Limited
Â
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 58 properties.
Â
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.
Â
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.